Results 241 to 250 of about 113,188 (264)
Some of the next articles are maybe not open access.
CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
Journal of Cellular and Molecular Medicine, 2016Oliver Ottmann +2 more
exaly
Molecular Therapy - Methods and Clinical Development, 2019
Joan Cid, Josep M Canals, Esteve Trias
exaly
Joan Cid, Josep M Canals, Esteve Trias
exaly

